ZA200604523B - An aerosol apparatus containing a composition for applying simultaneously several topical stimuli - Google Patents
An aerosol apparatus containing a composition for applying simultaneously several topical stimuli Download PDFInfo
- Publication number
- ZA200604523B ZA200604523B ZA200604523A ZA200604523A ZA200604523B ZA 200604523 B ZA200604523 B ZA 200604523B ZA 200604523 A ZA200604523 A ZA 200604523A ZA 200604523 A ZA200604523 A ZA 200604523A ZA 200604523 B ZA200604523 B ZA 200604523B
- Authority
- ZA
- South Africa
- Prior art keywords
- water
- based particles
- skin
- pain
- score
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 230000000699 topical effect Effects 0.000 title claims abstract description 6
- 239000000443 aerosol Substances 0.000 title claims description 40
- 239000002245 particle Substances 0.000 claims abstract description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000001816 cooling Methods 0.000 claims abstract description 31
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000003915 liquefied petroleum gas Substances 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- 239000007789 gas Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 208000003251 Pruritus Diseases 0.000 description 52
- 208000002193 Pain Diseases 0.000 description 46
- 210000003491 skin Anatomy 0.000 description 44
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 42
- 238000011282 treatment Methods 0.000 description 34
- 229960000890 hydrocortisone Drugs 0.000 description 21
- 230000007803 itching Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 201000008937 atopic dermatitis Diseases 0.000 description 18
- 206010012438 Dermatitis atopic Diseases 0.000 description 17
- 125000000017 cortisol group Chemical group 0.000 description 17
- 230000007423 decrease Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 9
- 206010015150 Erythema Diseases 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 8
- 230000003902 lesion Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000005336 cracking Methods 0.000 description 7
- 238000007427 paired t-test Methods 0.000 description 7
- 208000035874 Excoriation Diseases 0.000 description 6
- 206010024438 Lichenification Diseases 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 208000024780 Urticaria Diseases 0.000 description 5
- 239000004479 aerosol dispenser Substances 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 229940041616 menthol Drugs 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 208000007514 Herpes zoster Diseases 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 238000000585 Mann–Whitney U test Methods 0.000 description 4
- 206010027627 Miliaria Diseases 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 201000004169 miliaria rubra Diseases 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 206010012442 Dermatitis contact Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 206010033425 Pain in extremity Diseases 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 208000004550 Postoperative Pain Diseases 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 208000010247 contact dermatitis Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 208000025978 Athletic injury Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000001640 Fibromyalgia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027304 Menopausal symptoms Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010028836 Neck pain Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000008765 Sciatica Diseases 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000002169 hydrotherapy Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 201000011486 lichen planus Diseases 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000046 skin rash Toxicity 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000022925 sleep disturbance Diseases 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- JCAYXDKNUSEQRT-UHFFFAOYSA-N 2-aminoethoxyboronic acid Chemical compound NCCOB(O)O JCAYXDKNUSEQRT-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000006373 Bell palsy Diseases 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000018035 Dental disease Diseases 0.000 description 1
- 206010012468 Dermatitis herpetiformis Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 201000011275 Epicondylitis Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000007914 Labor Pain Diseases 0.000 description 1
- 208000035945 Labour pain Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000028373 Neck injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010034277 Pemphigoid Diseases 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 208000003782 Raynaud disease Diseases 0.000 description 1
- 208000012322 Raynaud phenomenon Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000208225 Rhus Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- 206010044074 Torticollis Diseases 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000037236 achy joints Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000000594 bullous pemphigoid Diseases 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- GZVBAOSNKYQKIT-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC.COCOC GZVBAOSNKYQKIT-UHFFFAOYSA-N 0.000 description 1
- 230000009266 disease activity Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000018197 inherited torticollis Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 206010035114 pityriasis rosea Diseases 0.000 description 1
- 210000004044 posterior horn cell Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 206010061928 radiculitis Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
- A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105216A EP1733753A1 (en) | 2005-06-14 | 2005-06-14 | An apparatus containing a composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200604523B true ZA200604523B (en) | 2007-09-26 |
Family
ID=35094114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200604523A ZA200604523B (en) | 2005-06-14 | 2006-06-02 | An aerosol apparatus containing a composition for applying simultaneously several topical stimuli |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070154405A1 (ja) |
| EP (3) | EP1733753A1 (ja) |
| JP (1) | JP2006346448A (ja) |
| CN (1) | CN100522272C (ja) |
| AT (1) | ATE414493T1 (ja) |
| AU (1) | AU2006202164B2 (ja) |
| CA (1) | CA2547322C (ja) |
| DE (1) | DE602006003684D1 (ja) |
| ZA (1) | ZA200604523B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007023641B4 (de) | 2007-05-22 | 2015-04-02 | Ibs Filtran Kunststoff-/ Metallerzeugnisse Gmbh | Ölfiltervorrichtung |
| JP5612914B2 (ja) * | 2010-06-15 | 2014-10-22 | 株式会社ダイゾー | エアゾール製品および該エアゾール製品の噴射方法 |
| FI124546B (en) * | 2012-01-19 | 2014-10-15 | Pkv Housing Oy | Cold Therapy Device |
| USD1015533S1 (en) | 2019-11-07 | 2024-02-20 | 623 Medical, Llc | Vapocoolant device |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413596A1 (fr) * | 1977-12-29 | 1979-07-27 | Oreal | Valve perfectionnee pour la distribution de melange pressurise inflammable |
| DE69006401T2 (de) * | 1989-05-19 | 1994-05-11 | Beecham Group Plc | Aerosolzusammensetzungen zur topischen Anwendung. |
| US5196459A (en) * | 1990-10-22 | 1993-03-23 | Fox Valley Systems, Inc. | Water-based aerosol coating compositions |
| FR2684874B1 (fr) * | 1991-12-13 | 1994-07-01 | Oreal | Systeme aerosol pour laque capillaire. |
| GB2273299A (en) * | 1992-12-08 | 1994-06-15 | Nelly Kamel Rizk | Mixture that produces cooling |
| US5269958A (en) * | 1993-01-13 | 1993-12-14 | S. C. Johnson & Son, Inc. | Self-pressurized aerosol spot dry cleaning compositions |
| EP0713386B1 (en) * | 1993-08-10 | 1998-11-18 | The Boots Company PLC | Spray formulation having a cooling effect |
| JPH09173926A (ja) * | 1995-12-28 | 1997-07-08 | Murata Mfg Co Ltd | 薬液散布装置 |
| US6199557B1 (en) * | 1997-10-08 | 2001-03-13 | Laughlin Products, Inc. | Method of and apparatus for automatically coating the human body |
| JP4176858B2 (ja) * | 1998-02-18 | 2008-11-05 | 久光製薬株式会社 | エアゾール製剤 |
| EP1195173B1 (en) * | 2000-04-17 | 2006-02-15 | Daizo Corporation | Intermittently sprayed aerosol product for skin |
| ES2354531T3 (es) * | 2000-09-22 | 2011-03-15 | Gebauer Company | Aparato para dispensar vaporrefrigerantes. |
| FR2815246B1 (fr) * | 2000-10-13 | 2003-01-24 | Cryonic Medical | Appareil autonome et portable de cryotherapie a usage grand public |
| US20030051728A1 (en) * | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
| JP3733524B2 (ja) * | 2001-07-27 | 2006-01-11 | 大日本除蟲菊株式会社 | マイクロエマルジョンエアゾール組成物 |
| GB0130057D0 (en) * | 2001-12-14 | 2002-02-06 | Dunne Stephen T | Liquid atomising system |
| US20030228374A1 (en) * | 2002-06-07 | 2003-12-11 | Pesacreta Thomas C. | Topical treatment for skin irritation |
| DE10252917A1 (de) * | 2002-11-12 | 2004-05-27 | Lothar Bode | Druckinjektions-Handgerät zum Einbringen von Substanzen unter Druck eines gasförmigen oder flüssigen Druckmittels in eine zu behandelnde Hautstelle |
| US7351747B2 (en) * | 2003-01-06 | 2008-04-01 | Gilbert Buchalter | Skin treatment for relief of itch |
-
2005
- 2005-06-14 EP EP05105216A patent/EP1733753A1/en not_active Withdrawn
- 2005-11-25 EP EP05111304A patent/EP1733754A1/en not_active Withdrawn
-
2006
- 2006-05-16 AT AT06090077T patent/ATE414493T1/de not_active IP Right Cessation
- 2006-05-16 DE DE602006003684T patent/DE602006003684D1/de active Active
- 2006-05-16 EP EP06090077A patent/EP1733755B1/en active Active
- 2006-05-23 US US11/419,879 patent/US20070154405A1/en not_active Abandoned
- 2006-05-23 AU AU2006202164A patent/AU2006202164B2/en not_active Ceased
- 2006-05-23 CA CA2547322A patent/CA2547322C/en active Active
- 2006-05-30 CN CNB2006100915097A patent/CN100522272C/zh not_active Expired - Fee Related
- 2006-06-02 JP JP2006154260A patent/JP2006346448A/ja active Pending
- 2006-06-02 ZA ZA200604523A patent/ZA200604523B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE414493T1 (de) | 2008-12-15 |
| EP1733753A1 (en) | 2006-12-20 |
| DE602006003684D1 (de) | 2009-01-02 |
| EP1733755B1 (en) | 2008-11-19 |
| AU2006202164B2 (en) | 2009-10-29 |
| CA2547322C (en) | 2012-01-03 |
| US20070154405A1 (en) | 2007-07-05 |
| AU2006202164A1 (en) | 2007-01-04 |
| JP2006346448A (ja) | 2006-12-28 |
| EP1733754A1 (en) | 2006-12-20 |
| CA2547322A1 (en) | 2006-12-14 |
| CN100522272C (zh) | 2009-08-05 |
| EP1733755A1 (en) | 2006-12-20 |
| CN1879904A (zh) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barkin | The pharmacology of topical analgesics | |
| Stanos | Topical agents for the management of musculoskeletal pain | |
| KR102026400B1 (ko) | 감각 불편의 치료를 위한 국소제 디-아이소프로필-포스피노일-알칸(dapa) 화합물 | |
| US6919348B2 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
| NO323573B1 (no) | Preparat inneholdende minst ett strontiumsalt, et aktivt middel, og minst ett middel valgt fra et hydrofilt middel og/eller et lipofilt middel og/eller et termal- eller mineralvann. | |
| JP2010531298A (ja) | 疼痛を治療するための局所用組成物 | |
| US20230201550A1 (en) | Systems and methods for treating persistent pain of neurogenic origin and complex injury | |
| US12029743B2 (en) | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort | |
| US9895382B2 (en) | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort | |
| EP1733755B1 (en) | An apparatus containing a composition | |
| US20200390844A1 (en) | Pain relieving system | |
| CA2940057C (en) | Transdermal composition for treating pain | |
| JP2005526841A (ja) | 治療用１，２，３，６−テトラヒドロピリミジン−２−オン組成物及びそれを用いた方法 | |
| CN116916931A (zh) | 1-二异丙基-磷酰基-烷烃化合物用于治疗眼部不适的用途 | |
| CN114533745A (zh) | 作为局部试剂用于治疗感觉不适的二异丙基膦酰基烷烃 | |
| JP4368072B2 (ja) | 皮膚外用剤 | |
| JP6564498B2 (ja) | 感覚的不快感の治療向け局所薬としてのジ−イソプロピル−アルカン（ｄａｐａ）化合物 | |
| WO2023215407A2 (en) | Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of eye diseases | |
| US20210290665A1 (en) | Topical composition for treatment of pain and symptoms associated with rhinosinusitis, method of making, and method of use | |
| Desbrosse | The analgesic properties of cryotherapy using hyperbaric CO2 | |
| Sermsilp et al. | Efficacy of topical botulinum toxin type A cream for treatment of primary axillary hyperhidrosis: a randomized, double-blinded, split site, vehicle control study | |
| Herndon | Itching |